Fortress Biotech Inc [NASDAQ: FBIO] loss -30.72% or -1.13 points to close at $2.56 with a heavy trading volume of 7309694 shares.
It opened the trading session at $2.47, the shares rose to $2.64 and dropped to $2.26, the range by which the price of stock traded the whole day. The daily chart for FBIO points out that the company has recorded 66.23% gains over the past six months.
If we look at the average trading volume of 739.89K shares, FBIO reached to a volume of 7309694 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Fortress Biotech Inc [FBIO]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for FBIO shares is $10.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on FBIO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
ROTH MKM have made an estimate for Fortress Biotech Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 15, 2024. While these analysts kept the previous recommendation, Ladenburg Thalmann raised their target price to Buy. The new note on the price target was released on August 04, 2022, representing the official price target for Fortress Biotech Inc stock. Previously, the target price had yet another raise to $9, while The Benchmark Company analysts kept a Buy rating on FBIO stock.
The Price to Book ratio for the last quarter was 1.73, with the Price to Cash per share for the same quarter was set at 2.50.
Trading performance analysis for FBIO stock
Fortress Biotech Inc [FBIO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -30.62. With this latest performance, FBIO shares dropped by -14.09% in over the last four-week period, additionally plugging by 66.23% over the last 6 months – not to mention a rise of 26.42% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for FBIO stock in for the last two-week period is set at 36.80, with the RSI for the last a single of trading hit 0.46, and the three-weeks RSI is set at 0.34 for Fortress Biotech Inc [FBIO]. The present Moving Average for the last 50 days of trading for this stock 2.71, while it was recorded at 3.56 for the last single week of trading, and 2.01 for the last 200 days.
Fortress Biotech Inc [FBIO]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Fortress Biotech Inc [FBIO] shares currently have an operating margin of -182.51% and a Gross Margin at 60.77%. Fortress Biotech Inc’s Net Margin is presently recorded at -40.56%.
Fortress Biotech Inc (FBIO) Capital Structure & Debt Analysis
According to recent financial data for Fortress Biotech Inc. ( FBIO), the Return on Equity (ROE) stands at -47.67%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -9.64%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Fortress Biotech Inc’s Return on Invested Capital (ROIC) is -22.43%, showcasing its effectiveness in deploying capital for earnings.
Fortress Biotech Inc (FBIO) Efficiency & Liquidity Metrics
Based on Fortress Biotech Inc’s (FBIO) latest financial statements, the Debt-to-Equity Ratio is 1.58%, indicating its reliance on debt financing relative to shareholder equity.
Fortress Biotech Inc (FBIO) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Fortress Biotech Inc. (FBIO) effectively leverages its workforce, generating an average of -$238118.81 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.92% and a Quick Ratio of 1.70%, indicating strong ability to cover short-term liabilities.
Fortress Biotech Inc [FBIO]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Fortress Biotech Inc posted -0.76/share EPS, while the average EPS was predicted by analysts to be reported at -0.27/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.49. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for FBIO. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Fortress Biotech Inc go to 9.86%.
An analysis of Institutional ownership at Fortress Biotech Inc [FBIO]
There are presently around $16.67%, or 21.10%% of FBIO stock, in the hands of institutional investors. The top three institutional holders of FBIO stocks are: ROSALIND ADVISORS, INC. with ownership of 0.61 million shares, which is approximately 3.3182%. VANGUARD GROUP INC, holding 0.54 million shares of the stock with an approximate value of $$0.93 million in FBIO stocks shares; and VANGUARD GROUP INC, currently with $$0.47 million in FBIO stock with ownership which is approximately 1.515%.
